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The monoclonal antibody ALB, directed against the leukocyte differentiation antigen CD9 (~24) increases 
the calcium incorporation into isolated platelet membrane vesicies enriched in internal membranes. The sim- 
ilarities of the effects of both the monoclonal antibody and the catalytic subunit of the CAMP-dependent 
protein kinase (C. subunit), which phosphorylates a protein of an apparent molecular mass of 23 kDa, led 
us to investigate the relationship between CD9 (~24) and the 23-kDa phosphoprotein (~23). ALB, IgG does 
not inhibit the C.subunit-induced phosphorylation of p23 and the immunoadsorption by ALB, IgG of ~24 
associated to membrane vesicles does not alter the phosphorylation pattern. Thus, proteins of similar molec- 
ular mass appear to be involved in calcium fluxes: one is recognized by the ALB, antibody while the other 
can be phosphorylat~ by the C-subunit. 
Platelet membrane Ca2+ transport Monoclonal antibody Cyclic AMP Phosphorylation 
1. INTRODUCTION 
In response to a wide variety of stimuli, an in- 
crease in cytosolic calcium ion concentration is 
supposed to be the trigger for activation of cellular 
processes. In blood platelets, calcium is thought to 
be implicated in shape change, secretion and ag- 
gregation [ 1,2]. Elevation of intracellular [Ca2’] 
may occur by an influx through the surface mem- 
brane [3] or the intracellul~ liberation of calcium 
associated with phospholipids 141. It may also oc- 
cur due to release of Ca2’ from intracellular 
storage sites or dense tubular system [2]. A platelet 
membrane fraction which sequesters calcium was 
first described by KPser-Glanzmann et al. [5]. The 
characterization and pharmacological regulation 
of a modified fraction have been studied [6,7] and 
we have been able to correlate this calcium 
transport with the activity of a (Ca2* + Mg’+)- 
ATPase [g]. Also, regulation of the calcium 
transport appears to proceed through a CAMP- 
dependent protein kinase-induced phosphorylation 
of a 23-kDa polypeptide [9]. Recently, a mono- 
clonal antibody called ALBe which recognizes a 
platelet membrane protein of similar molecular 
mass has been described [IO]. The antibody tested 
on platelet functions acts as an aggregating agent 
and is thought to be involved in calcium move- 
ments. The work reported here was designed to in- 
vestigate the effect of this monoclonal antibody on 
the calcium fluxes in the isolated platelet mem- 
branes enriched in internal membranes. The find- 
ings suggest he presence of two 23-kDa proteins 
which regulate calcium fluxes in human platelets. 
2. EXPERIMENTAL 
Abbreviations: SDS-PAGE, SDS-polyacrylamide gel The membrane fraction was isolated as 
electrophoresis; CAMP, cyclic adenosine 3,5 ‘-mono- previously described and has been found enriched 
phosphate in internal membranes. Briefly, washed platelets 
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were lysed by ultrasonication followed by differen- 
tial centrifugation at 19000 and 100000 x g. The 
100000 x g pellet was used in the experiments 
reported here. Characterization of this fraction has 
been made essentially using enzymatic activities as 
markers of the different contaminants [6,8]. The 
platelet membranes/whole platelet lysate average 
ratio was 1.44 for the plasma membrane marker 
enzyme phosphodiesterase. The specific activity of 
the endoplasmic reticulum marker enzyme, the an- 
timycin insensitive NADH-cytochrome c reduc- 
tase, was 9.0 relative to whole platelets. The 
calcium uptake into the membrane vesicles was 
measured on fresh material by incubating 0.2 ml 
of 100000 x g membrane fraction in a final reac- 
tion mixture of 2 ml constituted by 20 mM Hepes 
buffer (pH 8), 100 mM KCl, 10 mM potassium 
oxalate, 5 mM MgATP, 0.5 mM 45CaC12 
(1300-1500 cpm/nmol) and 0.5 mM EDTA. Free 
final calcium concentration was 1 FM. Calcula- 
tions were reported by Lotersztajn et al. [l l] using 
apparent association constants of 6.02 x lo*, 
9.7 x lo’, 9.55 x lo3 and 4.75 x lo4 M-’ for Ca 
EDTA, Mg EDTA, Ca ATP and Mg ATP, 
respectively. 
The reaction was started by adding the mem- 
brane suspension to the incubation medium and 
stirred at 37°C for different times. Aliquots of 
0.2 ml were withdrawn and filtered through 
Millipore HAWP filters (0.45 pm pore size) 
previously soaked in a 2 mg/ml bovine serum 
albumin solution. Filters were washed with 10 ml 
of 0.1 M CaClz and counted in 10 ml of Unisolve 
scintillation liquid. 
The monoclonal antibody tested here was pro- 
duced as described previously [12,13]. For this 
study, we used purified antibody fractions. IgG 
were obtained by precipitation in ammonium 
sulfate followed by ion exchange chromatography. 
After reprecipitation with ammonium sulfate 
ALB6 IgG was dissolved and dialysed against 
0.1 M phosphate buffer. ALBi (CDlO) and ALB9 
(CD24) monoclonal antibodies of the same IgG 
subclass were used as controls. CDro is a common 
antigen of human acute lymphoblastic leukemia 
and CD24 is a granulocyte and B cells lineage an- 
tigen [14]. The 100000 x g treatment for 
phosphorylation was as follows: platelet mem- 
brane vesicles were resuspended and lysed in cold 
buffer containing: 1% NP40, 1 mM EDTA, 2 mM 
PMSF, 5 mM ATP, 30 mM NaCl, 30 mM Tris 
(pH 7.0) and ultracentrifuged in an airfuge 
(Beckman) for 10 min at 100000 x g to eliminate 
the residual membranes. This extract was mixed 
gently with immunoadsorbents (glutaraldehyde- 
activated ultrogels coated with ALB6 IgG or ALBl 
IgG according to the technique of Kahn et al. [15] 
in order to retain the antigen defined by the 
monoclonal antibody ALBe. After centrifugation 
at 700 x g for 2 min, ultrogel pellets previously 
washed in 0.1 M phosphate buffer and super- 
natants were then phosphorylated. Phosphoryla- 
tions were carried out at 30°C for 10 min in a reac- 
tion mixture containing 10 mM MgS04, 100 mM 
NaF, 6 mM [32P]ATP (7.4 Ci/nmol), 25 mM 
sodium phosphate buffer (pH 7.0), in the presence 
or absence of the catalytic subunit of the CAMP- 
dependent protein kinase (enzyme/substrate: 
0.01). The reactions were initiated by addition of 
ATP. Supernatant protein phosphorylations were 
stopped by addition of 0.3 M HC104. After cen- 
trifugation, the precipitated proteins were 
resuspended in the following buffer: 0.0625 M Tris 
(pH 6.8) containing 2.5% SDS, 0.001% (v/v) 
bromophenol blue, 5% (v/v) sucrose, 5% (v/v) fl- 
mercaptoethanol. Ultrogel pellet protein phos- 
phorylations were stopped by addition of the same 
buffer (v/v). After dissociation for 10 min in boil- 
ing water, samples were applied to an SDS- 
polyacrylamide gradient gel (5-20%) according to 
Laemmli [16]. Electrophoresis was performed at 
30 volts overnight. Gels were stained with 
Coomassie brilliant blue and dried, then auto- 
radiographed using Kodak X-Omat AR films at 
- 80°C with intensifying screens. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the dose response relationship of 
ALB6 on the time course of calcium uptake by 
isolated platelet membranes enriched in internal 
membranes. The monoclonal antibody was added 
at time 0 of the calcium uptake study. As a control 
other monoclonal antibodies, ALB9 IgG (fig.1) 
and ALBl IgG (not shown) obtained under the 
same conditions, but which were without any ef- 
fect on platelet function, were used. It is clear that 
the monoclonal antibody induces an increase in the 
calcium incorporation into the membrane vesicles 
either by affecting the rate or the steady state level 
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Fig.1. Time course of the calcium uptake into isolated 
platelet membrane vesicles (lOOpg/ml) in the presence 
of different concentrations of the monoclonal antibody 
AI& IgG: c--o, 140 pg/ml; H , 280 gg/ml. The 
control ALB9 IgG was added at the final concentration 
of 280pg/ml, ti . 
which reaches a factor 1.8 when AL& IgG was 
used at 280pg/ml. This effect is not detectable 
when using 100 pM calcium concentration instead 
of 1 /tM. The stimulation depends on the ratio be- 
tween the immunoglobulin and the membrane vesi- 
cle protein concentration. A stimulation factor of 
1.5 was obtained in 5 different experiments when 
using a mean value of 1.2 for this ratio. Fig.1 
represents a typical experiment but similar results 
were obtained with different successive antibody 
preparations. 
To investigate further the effect of the 
monoclonal antibody, we compared the effect of 
CAMP, which phosphorylates a 23-kDa protein, 
on the calcium transport [9]. The experiments were 
conducted using the catalytic subunit of the CAMP 
dependent protein kinase (C. subunit) because of 
the very small amounts of endogenous CAMP- 
dependent protein kinase holoenzyme [6]. Fig.2 
shows that lOpg/ml C. subunit induces an in- 
crease in the calcium uptake reaching a factor 2 at 
the steady state level. The response is dose depen- 
dent at enzyme concentrations of 5-lO~g/ml. 
These results differ from those obtained with high 
calcium concentrations but they allow us to explain 
the transient stimulation by C. subunit on calcium 
uptake we observed [6] in the first 2-5 min and the 
more pronounced stimulation from 0.5-5 min 
noted by Kgiser-Glanzmann et al. [5]. Such a 
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Fig.2. Time course of calcium uptake into isolated 
platelet membrane vesicles (380pg/ml) in the presence 
of different concentrations of C. subunit (Sigma) 
dissolved in water immediately prior to use: o---o, 
5 pg/ml; A--A , 7.5 pg/ml; If--Ii , lOpg/ml, or 
M, in the absence of C. subunit. 
modulation of the effect of CAMP as a function of 
the calcium concentration has been previously 
described in the cardiac system [131. Moreover, the 
C. subunit-induced increase of calcium uptake is 
obtained with very low Ca2+ concentration (1 FM) 
which is consistent with the inhibitory role of 
CAMP on platelet activation. 
The similarities of the effects of both the 
monoclonal antibody and the C. subunit, added to 
the fact that they act on proteins of the same 
molecular mass, led us to investigate the relation- 
ship between these two effecters. This was carried 
out by experiments on calcium transport and 
phosphorylation in the presence of AL& IgG 
together with C. subunit. 
Fig.3 shows the results obtained on calcium 
transport: both effecters are incubated with the 
membrane fraction under conditions where each 
effector involved a stimulation by itself. We can 
see that in the presence of an almost saturating 
amount of AL& IgG the steady state level does not 
increase by adding suboptimal concentrations of 
C. subunit. To determine if both effecters are 
directed to the same target, we then continued the 
investigations through the phosphorylation ex- 
periments induced by the C. subunit. The 
monoclonal antibody ALB6 added to the same in- 
cubating medium never modified the C. subunit- 
induced phosphorylation of the 23-kDa protein 
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Fig.3. Effect of ALBa IgG and C. subunit on calcium 
uptake into membrane vesicles. Membrane proteins 
(194 pg/ml) were incubated with buffer f~) or with 
ALB,s IgG (W) 240 pg/ml, or C. subunit (cr---rr) 
Spg/ml, or both proteins (H). 
(not shown). This result was obtained either by in- 
creasing AL& IgG concentrations and keeping a 
constant C. subunit concentration or by varying C. 
subunit concentrations in the presence of a fixed 
ALB6 IgG concentration. Hence, it is likely that 
the monoclonal antibody and the enzyme 
recognize two different sites. 
To define whether these two sites belong to one 
or two proteins, immunoadsorption experiments 
were then carried out. Platelet membranes were 
treated with immunoadsorbents to eliminate the 
protein recognized by the antibody and then sub- 
mitted to phosphorylation procedures in the 
presence of the C. subunit. 
Results are given in fig.4: on the left side (A), 
one can see the efficiency of the immunoadsorp- 
tion treatment because an ultrogel adsorbed pro- 
tein of 23 kDa appears after incubation with ALBa 
but not with ALBr (lanes 2 and 1). This result was 
confirmed in a qu~titative manner as assessed by 
the enzyme-linked immunoadsorbent assay (not 
shown). On the right side of the figure (C), we can 
see that the phosphorylation still occurs when the 
membrane vesicles are depleted in the protein 
recognized by the monoclonal antibody: 
phospho~lation intensities are the same in lanes 1 
and 2. This result is confirmed by the absence of 
phosphorylation of the protein recognized by 
ALB6 as shown on (B) of the same figure. Thus the 
1 2 1 2 1 2 
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Fig.4. SDS-PAGE autoradiograms of platelet 
membrane proteins phosphorylated byC. subunit after 
immunoadso~tion treatment described in section 2. The 
membrane vesicles were treated with the immuno- 
adsorbents linked to monoclonal antibodies ALB6 (2) 
and ALBI (1) as a contro1. Membrane vesicles (1500 /cg/ 
ml) were incubated for phosphorylations with the C. 
subunit (25 ag/ml). (A) and (B) refer to ultrogel ad- 
sorbed proteins: (A) SDS-PAGE, (B) autoradiograms, 
(C) autoradio~ams of treated membrane vesicles. The 
figure represents the molecular mass of the following 
markers: phosphorylase 6, bovine serum albumin, 
ovalbumin, carbonic anhydrase, soybean trypsin 
inhibitor, lactalbumin. 
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immunoadsorption treatment allows us to isolate a 
23-kDa protein which is not phosphorylated by the 
C. subunit. It seems, then, different from the 
phosphoprotein. 
In summary, previous work has shown that the 
antibody recognized a 24-kDa protein in the exter- 
nal membranes which has been shown to be in- 
volved in platelet aggregation [lo]; it now seems 
that it also recognizes a protein of the same 
molecular mass in a 100000 x g fraction enriched 
in internal membranes which actively sequesters 
calcium. These results raise different hypotheses: 
(i) ALBa IgG recognizes a 24-kDa protein of the 
external membranes and we cannot exclude a con- 
tamination of the 100000 x g fraction by these 
membranes; the binding of the monoclonal an- 
tibody to this antigen could interfere with the 
ATPase associated with the external membranes 
and could account for the observed stimulation of 
calcium uptake. Boucheix et al. [lo] proposed that 
the ALB6 platelet interaction could involve a 
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calcium channel, which suggests that a relationship 
between the different systems would exist in 
calcium transport, i.e., ATPase pump and calcium 
channel. However, we cannot exclude that either 
the increase of calcium uptake or the activation of 
whole platelets induced by this antibody is directly 
triggered by the interaction of the antigen: this 
calcium effect could be the secondary effect of an 
activation process. 
(ii) AL& IgG might recognize a protein on inter- 
nal membranes which would be different from the 
phosphoprotein and which would play a role on 
calcium uptake. Then the use of the AL& 
monoclonal antibody and the C. subunit allowed 
us to distinguish between two proteins of the same 
molecular mass, both involved in calcium fluxes. 
Interestingly, both sarcolemmal and sarcoplasmic 
reticulum membranes in the cardiac system have 
been described as bearing a 23-kDa protein which 
modulates calcium fluxes. The activator of the 
(Ca’+ + Mg’+)-ATPase is the phospholamban 
which binds the enzyme of the sarcoplasmic 
reticulum [18] and the calciductin is suggested to 
constitute the gate responsible for opening the sur- 
face membrane Ca2+ channel [ 191. These latter 
proteins would differ by their isoelectric point and 
their capacity to be phoshorylated [19]. The ques- 
tion of the similarities between the two proteins is 
still open [20-221. A salient feature of the results 
presented here is that there exists a family of pro- 
teins of similar molecular mass which regulate 
calcium movements directly or indirectly. A more 
profound study of the structure of the platelet pro- 
teins and their involvement in calcium fluxes is be- 
ing further investigated on purified external and 
internal platelet membranes [23]. 
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